Physician profile
Casey M Brown
NPI 1578724647
$4,974.18
in general payments reported to CMS, 2019-2025
18 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $146 · 2021: $449 · 2022: $850 · 2023: $672 · 2024: $668 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $957.97 | 2019-2025 | Tryptyr, Precision7, Rocklatan |
| Coopervision INC. | $744.18 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $689.12 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $524.84 | 2022-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $503.08 | 2019-2025 | Cequa |
| Allergan, INC. | $252.12 | 2019-2022 | |
| New World Medical,INC. | $238.77 | 2022-2023 | |
| Biotissue Holdings INC. | $168.25 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $162.04 | 2019-2021 | |
| Sight Sciences, INC. | $147.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $122.08 | 2019 | |
| Glaukos Corporation | $102.30 | 2019 | |
| Dompe US, INC. | $100.10 | 2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $94.91 | 2019 | |
| Harrow Eye, LLC | $80.52 | 2025 | Vevye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $32.57 | 2022-2023 | Tyrvaya |
| Thea Pharma INC. | $29.26 | 2022-2023 | |
| Abbvie INC. | $24.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.